tiprankstipranks
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (HK:1541)
:1541
Hong Kong Market
1541
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H
RESEARCH TOOLSreports
Want to see HK:1541 full AI Analyst Report?

ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (1541) Cash flow

3 Followers

ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H Cash Flow

HK:1541's free cash flow for Q4 2025 was ¥-73.16M. For the 2025 fiscal year, HK:1541's free cash flow was decreased by ¥-58.69M and operating cash flow was ¥-72.41M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
¥ -195.85M¥ -128.03M¥ -367.55M¥ -238.71M¥ -190.54M
Investing Cash Flow
¥ 2.82M¥ 37.95M¥ -294.85M¥ 49.00K¥ -108.72M
Financing Cash Flow
¥ 397.11M¥ 258.93M¥ 331.04M¥ 179.38M¥ 793.03M
End Cash Position
¥ 679.85M¥ 477.60M¥ 306.98M¥ 635.21M¥ 668.33M
Free Cash Flow
¥ -197.13M¥ -138.44M¥ -370.25M¥ -261.93M¥ -315.79M
Currency in CNY

ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H Cash Flow